Mark J. Foley - 06 Mar 2024 Form 4 Insider Report for Revance Therapeutics, Inc.

Signature
/s/ Dwight Moxie, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
06 Mar 2024
Net transactions value
+$209,400
Form type
4
Filing time
08 Mar 2024, 16:33:10 UTC
Previous filing
04 Mar 2024
Next filing
19 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Purchase $209,400 +30,000 +3% $6.98 1,015,468 06 Mar 2024 Direct F1
holding RVNC Common Stock 110,913 06 Mar 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person purchased shares of common stock in an underwritten public offering by the issuer that closed on March 6, 2024.
F2 These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002.